awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q42202640-12434C35-5357-4957-9689-D73AFE056448
Q42202640-12434C35-5357-4957-9689-D73AFE056448
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42202640-12434C35-5357-4957-9689-D73AFE056448
Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study.
P2860
Q42202640-12434C35-5357-4957-9689-D73AFE056448
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42202640-12434C35-5357-4957-9689-D73AFE056448
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
af36f03121ab1ba9b34d80053da54476351f2076
P2860
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial.